EMMANUEL ANYANWU: Open Payments
NPI 1912417130 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 34 payments from 5 companies in 2025. Trend: 2023 $740 · 2024 $1,362 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $325 |
| ABBVIE INC. | 15 | $181 |
| Otsuka America Pharmaceutical, Inc. | 6 | $138 |
| Teva Pharmaceuticals USA, Inc. | 1 | $61 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: ARISTADA, VRAYLAR, REXULTI, LYBALVI, AUSTEDO XR, Qelbree.
Industry payments across NJ — which companies pay providers there.
